new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Abbvie Deutschland Gmbh x26 Co Kg
Abbvie Deutschland Gmbh x26 Co Kg_20131212
  

Abbvie Deutschland Gmbh & Co Kg patents

Recent patent applications related to Abbvie Deutschland Gmbh & Co Kg. Abbvie Deutschland Gmbh & Co Kg is listed as an Agent/Assignee. Note: Abbvie Deutschland Gmbh & Co Kg may have other listings under different names/spellings. We're not affiliated with Abbvie Deutschland Gmbh & Co Kg, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Abbvie Deutschland Gmbh & Co Kg-related inventors




Date Abbvie Deutschland Gmbh & Co Kg patents (updated weekly) - BOOKMARK this page
03/23/17Therapy for complications of diabetes
03/16/17Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use
03/16/17Methods for treating relapsing forms of multiple sclerosis
03/02/17Fused heterocyclic compounds as s1p modulators
02/23/17Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
02/09/17Guanidine compounds and use thereof as binding partners for 5-ht5 receptors
01/26/17Anti-aß globulomer 4d10 antibodies
01/19/17Formulations of nonopioid and confined opioid analgesics
01/12/17Ager-peptides and use thereof
01/05/17Oxindole derivatives carrying an amine-substituted piperidyl-azetidinyl substituent and use thereof for treating vasopressine-related diseases
01/05/17Antibodies to receptor of advanced glycation end products (rage) and uses thereof
12/15/16Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
11/10/16Abeta conformer selective anti-abeta globulomer monoclonal antibodies
11/10/16Composition and the diagnosis and treatment of diseases associated with neurite degeneration
11/03/16Novel inhibitor compounds of phosphodiesterase type 10a
10/20/16Substituted pyrazolopyrimidines and use
07/07/16Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
06/16/16Nampt inhibitors
06/09/16Monoclonal antibodies against amyloid beta protein and uses thereof
05/26/16Neutralizing monoclonal antibodies against the nogo-66 receptor (ngr) and uses thereof
05/19/16Method for producing monolithic tablets
05/19/16Novel inhibitor compounds of phosphodiesterase type 10a
04/07/16Modulators of 5-ht receptors and methods of use thereof
03/31/16Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
03/17/164,5- dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
03/17/16Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
03/10/16Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases
03/10/16Rgma fragment based diagnostic assay
03/03/16Radiolabeled pde10a ligands
01/21/16Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
01/21/16Tricyclic quinoline and quinoxaline derivatives
01/14/16Novel poly(adp-ribose) polymerase genes
01/07/16Immunogenic products based on mutein amyloid beta (abeta) amino acid sequences and uses thereof
01/07/16Novel inhibitor compounds of phosphodiesterase type 10a
12/24/15Amyloid-beta binding proteins
12/10/15Substituted oxindole derivatives and their use as vasopressin receptor ligands
12/03/15Oxindole compounds carrying a co-bound spiro substituent and use thereof for treating vasopressin-related diseases
11/19/15Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases
11/05/15Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
10/01/15Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
09/17/15Solid antiviral dosage forms
09/17/15Hexahydrodiazepinoquinolines carrying a cyclic radical
09/17/15Hexahydrodiazepinoquinolines carrying a substituted alkyl radical
09/10/15Carboxamide compounds and their use as calpain inhibitors v
08/06/15Substituted oxindole derivatives, medicaments containing said derivatives and use thereof
08/06/15Amyloid-beta binding proteins
07/02/155-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors
07/02/15Antibodies against the rgm a protein and uses thereof
06/25/15Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
06/25/15Modulators of 5-ht receptors and methods of use thereof
06/25/15Abeta conformer selective anti-abeta globulomer monoclonal antibodies
06/11/15Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
06/11/155-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases
05/28/15Melt-extruded solid dispersions containing an apoptosis-inducing agent
05/21/15Solid pharmaceutical compositions
04/30/15Composition and the diagnosis and treatment of diseases associated with neurite degeneration
04/23/15Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
04/23/15Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
04/16/154-(4-pyridinyl)-benzamides and their use as rock activity modulators
04/09/15Carboxamide compounds and their use as calpain inhibitors
03/19/15Method for the treatment of amyloidoses
03/12/15Monoclonal antibodies against amyloid beta protein and uses thereof
02/19/15Therapy for complications of diabetes
02/12/15Carboxamide compounds and their use as calpain inhibitors
02/05/15Human antibodies that bind human il-12 and methods for producing
Patent Packs
09/25/14Anti-egfr antibody drug conjugate formulations
07/17/14Pharmaceutical dosage form comprising polymeric carrier composition
04/03/14Process for producing a solid dispersion of an active ingredient
03/27/14Process for producing a solid dispersion of an active ingredient
01/02/14Carboxamide compounds and their use as calpain inhibitors v
12/12/13Composition and the diagnosis and treatment of iron-related disorders
12/12/13Composition and the diagnosis and treatment of diseases associated with neurite degeneration
12/12/13Composition and the diagnosis and treatment of iron-related disorders
11/21/134-(4-pyridinyl)-benzamides and their use as rock activity modulators
09/19/13Method for selecting or identifying a subject for v1b antagonist therapy
08/15/13Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/08/13Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
07/11/13Therapy for complications of diabetes
06/27/13Ibuprofen and narcotic analgesic compositions
05/23/13N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
Patent Packs
12/12/13Composition and the diagnosis and treatment of iron-related disorders







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Abbvie Deutschland Gmbh & Co Kg in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Abbvie Deutschland Gmbh & Co Kg with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';